Elicio Therapeutics (ELTX) Stock Price, Quote, News & History | Benzinga

SPY776.10+0.16%QQQ757.88 BTC/USD85,769.00+0.02%DIA514.43+0.45%GLD380.60+0.28%TLT77.56+0.58%

Elicio Therapeutics Inc (ELTX) Stock Price, Quote, News & History

ELTXNASDAQ

Trade with Public

Trade with Public

$1.92

N/A

Last update: Oct 5, 7:53 PM

$1.89

-0.03-1.56%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$1.92

Volume / Avg.

5.00 / 507.85K

Day Range

- - -

52 Wk Range

1.71 - 16.00

Market Cap

$49.67M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

8.17%

Days to Cover

4.44

Recent Elicio Therapeutics Inc News

Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Smith & Wesson (SWBI) shares rose in pre-market trading after posting strong Q4 results, beating earnings and revenue estimates. Other gainers include LNKS, ADTX, and SPRO.

Avi Kapoor

Elicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer Drug

Elicio shares complete response data for ELI-002 7P in KRAS pancreatic cancer and plans combination studies after mixed Phase 2 results.

Vandana Singh

Elicio Therapeutics Pancreatic Cancer Study Disappoints

Elicio Therapeutics reports mixed Phase 2 pancreatic cancer results, identifies key patient subgroup benefit, and outlines Phase 3 plans.

Vandana Singh

Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June

US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech shares jump 2.8%, energy stocks fall 3.5%. Empire State manufacturing index drops to 5.7. Industrial production up 0.1%. Housing market index declines to 35.

Avi Kapoor

Dow Jumps Over 600 Points Following US-Iran Peace Deal

US stocks rise on peace agreement with Iran, Dow up 600 points. Tech sector jumps, energy stocks down. Trump announces deal, oil futures decline.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-37.69M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

38.97M

Free Cash Flow (TTM)

-37.71M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

1.26M

Analyst Trends and Forecast

1

Apr

1

May

3

Jun

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$40.87M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

6.32

Earnings Yield % (TTM)

-112.57%

Earnings Yield % (FWD)

-72.25%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.30

Company Debt

Total Debt

$9.54M

LT Debt

$9.54M

LT Debt Issuance (TTM)

-$9.87M

LT Debt Repayment (TTM)

-

Total Cash

$23.48M

Debt to Equity

1.78

Issuance of Debt (TTM)

-$9.87M

Repayment of Debt (TTM)

-